Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: Possible correlation with sensitivity to chemotherapy

Blood

Volumn 90, Issue 12, 1997, Pages 4901-4909

  Iijima, Narikazu ^b   Miyamura, Koichi ^a   Itou, Toshihide ^b   Tanimoto, Mitsune ^b   Sobue, Ryou ^b   Saito, Hidehiko ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CD38 ANTIGEN; DNA FRAGMENT; FAS ANTIGEN; RECOMBINANT GAMMA INTERFERON;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031440744     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4901.4901_4901_4909     Document Type: Article

References (30)

1. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
2. Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R: Allogeneic cell therapy for relapse leukemia after bone marrow transplantaion with donor peripheral blood lymphocytes. Exp Hematol 23:1553, 1995
3. Higuchi CM, Thompson JA, Cox T, Lindgren CG, Buckner CD, Fefer A: Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies. Cancer Res 49:5509, 1989
4. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
5. Yonehara S, Ishii A,Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
6. Ito N, Yonehara S, Ishi A, Yonehara M, Mizushima S, Sameshima S, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
7. Tartaglia LA, Ayres TM, Wong GV, Goeddele DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845, 1993
8. Hata H, Matsuzaki H, Takeya M, Yoshida M, Sonoki T, Nagasaki A, Kuribayashi N, Kawano F, Takatsuki K: Expression of Fas/ Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 86:1939, 1995
9. Debatin KM, Goldman CK, Waldmann TA, Krammer PH: APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia Blood 81:2972, 1993
10. Griffin JM, Loewenberg B: Clonogenic cells in acute myeloblastic leukemia. Blood 68:1185, 1986
11. Lapidot T, Sirard C, Vormoor J, Murdock B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Carigiuri MA, Dick JE: A cell initiating AML after transplantation into SCID mice. Nature 367:645, 1994
12. Mehrotra B, George TI, Kavanau K, Avet LH, Moore D, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG: Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 86:1139, 1995
13. Haase D, Feuring-Buske M, Konemann S, Fonatsch C, Troff C, Verbeek W, Pekrun A, Hiddemann W, Wormann B: Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 86:2906, 1995
14. Raymakers R, Wittebol S, Pennings A, Linders E, Poddighe P, De-Witte T: Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+). Leukemia 9:450, 1995
15. Munker R, Lubbert M, Yonehara S, Tuchnitz A, Mertelsmann R, Wilmanns W: Expression of the Fas antigen on primary human leukemia cells. Ann Hematol 70:15, 1995
16. Komada Y, Zhou YW, Zhang XL, Xue HL, Sakai H, Tanaka S, Sakatoku H, Sakurai M: Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 86:3848, 1995
17. Westendorf JJ, Lammert LM, Jelinek DF: Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85:3566, 1995
18. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV: Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell Leukemia. Leukemia 9:1227, 1995
19. Maciejewski J, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor a potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
20. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
21. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okumura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
22. Takahashi H, Kobayashi H, Hashimoto Y, Matsuo S, Iizuka H: Interferon-γ-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: Modulation of the apoptotic process by protein kinase C. J Invest Dermatol 105:810, 1995
23. Massia M, Borrione P, Attisano C, Barral P, Beggiato E, Montacchini L, Bianchi A, Boccadoro M, Pileri A: Dysregulated Fas and bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood 85:3679, 1995
24. Debatin KM, Krammer PH: Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. Leukemia 9:815, 1995
25. Collins R, Shpilberg O, Drobyski W, Porter D, Antin J, Wollf S, Giralt S, Chetrit A, Ognoskie N, Prine S, Nemunatis J: Donor leukocyte infusion for post-bone marrow transplant relapse retrospective cohort analysis of 141 cases. Blood 86:563, 1995
26. Stalder T, Hahn S, Erb P: Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152:1127, 1994
27. Friessen C, Herr I, Krammer P, Debatin K-M: Involvement of the CD95(APO1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 2:574, 1996
28. Mashima T, Naito M, Kataoka S, Kawai H, Tsuruo T: Asparate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem Biophys Res Commun 209:907, 1995
29. Landowski T, Gleason-Guzman M, Dalton W: Selection for drug resistant results in resistance to Fas-mediated apoptosis. Blood 89:1854, 1997
30. Barcena A, Park S, Banapour B, Muench M, Mechetner E: Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013, 1997